Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors

BACKGROUND: The modified Glasgow Prognostic Score (mGPS) is a composite biomarker that uses albumin and C reactive protein (CRP). There are multiple immune checkpoint inhibitor (ICI)-based combinations approved for metastatic renal cell carcinoma (mRCC). We investigated the ability of mGPS to predic...

詳細記述

保存先:
書誌詳細
出版年:J Immunother Cancer
主要な著者: Brown, Jacqueline T, Liu, Yuan, Shabto, Julie M, Martini, Dylan, Ravindranathan, Deepak, Hitron, Emilie Elise, Russler, Greta Anne, Caulfield, Sarah, Yantorni, Lauren, Joshi, Shreyas Subhash, Kissick, Haydn, Ogan, Kenneth, Nazha, Bassel, Carthon, Bradley C, Kucuk, Omer, Harris, Wayne B, Master, Viraj A, Bilen, Mehmet Asim
フォーマット: Artigo
言語:Inglês
出版事項: BMJ Publishing Group 2021
主題:
Immunotherapy Biomarkers
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8323383/
https://ncbi.nlm.nih.gov/pubmed/34326170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2021-002851
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料